We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+9.14%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$22.8B
AUM Growth
+$2.32B
(+11%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-2.13%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
1,019
New
29
Increased
317
Reduced
427
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$47M |
| 2 |
Qiagen
QGEN
|
+$31.1M |
| 3 |
Elanco Animal Health
ELAN
|
+$29.5M |
| 4 |
Amazon
AMZN
|
+$27.9M |
| 5 |
Tesla
TSLA
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
Charter Communications
CHTR
|
+$79.7M |
| 3 |
Comcast
CMCSA
|
+$70.1M |
| 4 |
Stellantis
STLA
|
+$55.4M |
| 5 |
Union Pacific
UNP
|
+$43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.87% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 11.73% |
| 5 | Communication Services | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Exelixis
EXEL
$13.9B
| – | – |
-54,461
| Closed | -$1.23M |
|
852
EXL Service
EXLS
$5.5B
| – | – |
-68,425
| Closed | -$1.23M |
|
853
Exponent
EXPO
$3.19B
| – | – |
-12,783
| Closed | -$1.25M |
|
854
Franklin Electric
FELE
$4.66B
| – | – |
-15,562
| Closed | -$1.23M |
|
855
FIVE9
FIVN
$2.08B
| – | – |
-7,502
| Closed | -$1.17M |
|
856
Flowers Foods
FLO
$1.58B
| – | – |
-50,704
| Closed | -$1.21M |
|
857
Fabrinet
FN
$14.9B
| – | – |
-13,913
| Closed | -$1.26M |
|
858
Freshpet
FRPT
$3.04B
| – | – |
-8,241
| Closed | -$1.31M |
|
859
Forward Air
FWRD
$461M
| – | – |
-13,998
| Closed | -$1.24M |
|
860
Guardant Health
GH
$19.1B
| – | – |
-8,848
| Closed | -$1.35M |
|
861
Globus Medical
GMED
$11.1B
| – | – |
-19,827
| Closed | -$1.22M |
|
862
Haemonetics
HAE
$3.88B
| – | – |
-10,334
| Closed | -$1.15M |
|
863
Hain Celestial
HAIN
$44.6M
| – | – |
-27,811
| Closed | -$1.21M |
|
864
Heartland Express
HTLD
$1.01B
| – | – |
-62,797
| Closed | -$1.23M |
|
865
ICU Medical
ICUI
$4.16B
| – | – |
-5,726
| Closed | -$1.18M |
|
866
Inspire Medical Systems
INSP
$1.47B
| – | – |
-6,153
| Closed | -$1.27M |
|
867
Iovance Biotherapeutics
IOVA
$2.04B
| – | – |
-40,108
| Closed | -$1.27M |
|
868
John B. Sanfilippo & Son
JBSS
$986M
| – | – |
-13,551
| Closed | -$1.23M |
|
869
J&J Snack Foods
JJSF
$1.49B
| – | – |
-7,578
| Closed | -$1.19M |
|
870
Kilroy Realty
KRC
$4.59B
| – | – |
-127,423
| Closed | -$8.36M |
|
871
Krystal Biotech
KRYS
$10.7B
| – | – |
-17,198
| Closed | -$1.32M |
|
872
Kura Oncology
KURA
$793M
| – | – |
-48,073
| Closed | -$1.36M |
|
|
MZTI
873
The Marzetti Company
MZTI
$3.05B
| – | – |
-6,618
| Closed | -$1.16M |
|
874
Lincoln Electric
LECO
$14.1B
| – | – |
-9,773
| Closed | -$1.2M |
|
875
Littelfuse
LFUS
$10.4B
| – | – |
-4,664
| Closed | -$1.23M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2021 Portfolio in Review
As of Q2 2021, Aviva held 1,019 positions worth $22.8B, up 11% from $20.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Aviva's Q2 2021 filing shows 29 new, 317 increased, 427 reduced and 158 closed positions. Its largest new stake was DoorDash: 44,570 shares worth $7.95M. The largest sale was Alibaba, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2021 buy was DoorDash: 44,570 shares worth $7.95M.
- Aviva added most to Meta Platforms (Facebook) in Q2 2021, an estimated $47M increase.
- Aviva's biggest Q2 2021 reduction was Alibaba, cutting an estimated $138M.
- Aviva fully exited Kilroy Realty in Q2 2021, selling an estimated $8.36M.
- Aviva's ten largest holdings make up 23% of its $22.8B portfolio in Q2 2021.
- Aviva opened 29 new positions and closed 158 in Q2 2021.
- Aviva's portfolio value rose 11% quarter-over-quarter to $22.8B.
Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.